Effects of a new nutraceutical combination on cognitive function in hypertensive patients

Giuseppe Giugliano, Alessia Salemme, Sara De Longis, Marialuisa Perrotta, Valentina D'Angelosante, Alessandro Landolfi, Raffaele Izzo, Valentina Trimarco

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Chronic increased arterial blood pressure has been associated with executive dysfunction, slowing of attention and mental processing speed, and later with memory deficits. Due to the absence of a concrete therapeutic approach to this pathophysiological process, in the last decades there has been an increasing interest in the use of nutraceuticals, especially those with antioxidant properties, which own strong neuroprotective potential, that may help to improve cognitive function and to delay the onset of dementia. Results: We evaluated the effects of the treatment with a new nutraceutical preparation containing different molecules with potent antioxidant properties (AkP05, IzzeK®) and placebo on a cohort of thirty-six hypertensive patients. At baseline, neuropsychological evaluation, arterial stiffness and biochemical parameters of the subjects were comparable. After 6 months of treatment, there was a significant reduction of the augmentation index in the AkP05-treated group. Moreover, the measurement of cognitive function, evaluated with MoCA test and Word Match Testing, showed a significant improvement in patients receiving the active treatment. In addition, the group treated with nutraceutical reached a better Stroop test score, while subjects that received placebo did not showed any improvement. Finally, a positive relationship between SBP variation and the psychometric assessment with the EQ-VAS scale was observed only in the active treatment group. Conclusions: In this study, we demonstrated that the therapy with a new nutraceutical preparation is able to significantly increase the scores of important neuropsychological tests in hypertensive patients already on satisfactory blood pressure control. Although future studies are needed to better characterize the molecular mechanisms involved, these results candidate the new nutraceutical combination as a possible therapeutic strategy to support the cerebrovascular functions and delay the onset of dementia in hypertensive patients.

Original languageEnglish
Article number7
JournalImmunity and Ageing
Volume15
Issue number1
DOIs
Publication statusPublished - Feb 7 2018

Fingerprint

Dietary Supplements
Cognition
Therapeutics
Dementia
Antioxidants
Placebos
Stroop Test
Vascular Stiffness
Neuropsychological Tests
Memory Disorders
Psychometrics
Arterial Pressure
Blood Pressure

Keywords

  • Arterial stiffness
  • Neuropsychological evaluation
  • Nutraceutical

ASJC Scopus subject areas

  • Immunology
  • Ageing

Cite this

Giugliano, G., Salemme, A., De Longis, S., Perrotta, M., D'Angelosante, V., Landolfi, A., ... Trimarco, V. (2018). Effects of a new nutraceutical combination on cognitive function in hypertensive patients. Immunity and Ageing, 15(1), [7]. https://doi.org/10.1186/s12979-017-0113-4

Effects of a new nutraceutical combination on cognitive function in hypertensive patients. / Giugliano, Giuseppe; Salemme, Alessia; De Longis, Sara; Perrotta, Marialuisa; D'Angelosante, Valentina; Landolfi, Alessandro; Izzo, Raffaele; Trimarco, Valentina.

In: Immunity and Ageing, Vol. 15, No. 1, 7, 07.02.2018.

Research output: Contribution to journalArticle

Giugliano, G, Salemme, A, De Longis, S, Perrotta, M, D'Angelosante, V, Landolfi, A, Izzo, R & Trimarco, V 2018, 'Effects of a new nutraceutical combination on cognitive function in hypertensive patients', Immunity and Ageing, vol. 15, no. 1, 7. https://doi.org/10.1186/s12979-017-0113-4
Giugliano, Giuseppe ; Salemme, Alessia ; De Longis, Sara ; Perrotta, Marialuisa ; D'Angelosante, Valentina ; Landolfi, Alessandro ; Izzo, Raffaele ; Trimarco, Valentina. / Effects of a new nutraceutical combination on cognitive function in hypertensive patients. In: Immunity and Ageing. 2018 ; Vol. 15, No. 1.
@article{c6fe06e1a9d34a9fbd3a862dac3e8e57,
title = "Effects of a new nutraceutical combination on cognitive function in hypertensive patients",
abstract = "Background: Chronic increased arterial blood pressure has been associated with executive dysfunction, slowing of attention and mental processing speed, and later with memory deficits. Due to the absence of a concrete therapeutic approach to this pathophysiological process, in the last decades there has been an increasing interest in the use of nutraceuticals, especially those with antioxidant properties, which own strong neuroprotective potential, that may help to improve cognitive function and to delay the onset of dementia. Results: We evaluated the effects of the treatment with a new nutraceutical preparation containing different molecules with potent antioxidant properties (AkP05, IzzeK{\circledR}) and placebo on a cohort of thirty-six hypertensive patients. At baseline, neuropsychological evaluation, arterial stiffness and biochemical parameters of the subjects were comparable. After 6 months of treatment, there was a significant reduction of the augmentation index in the AkP05-treated group. Moreover, the measurement of cognitive function, evaluated with MoCA test and Word Match Testing, showed a significant improvement in patients receiving the active treatment. In addition, the group treated with nutraceutical reached a better Stroop test score, while subjects that received placebo did not showed any improvement. Finally, a positive relationship between SBP variation and the psychometric assessment with the EQ-VAS scale was observed only in the active treatment group. Conclusions: In this study, we demonstrated that the therapy with a new nutraceutical preparation is able to significantly increase the scores of important neuropsychological tests in hypertensive patients already on satisfactory blood pressure control. Although future studies are needed to better characterize the molecular mechanisms involved, these results candidate the new nutraceutical combination as a possible therapeutic strategy to support the cerebrovascular functions and delay the onset of dementia in hypertensive patients.",
keywords = "Arterial stiffness, Neuropsychological evaluation, Nutraceutical",
author = "Giuseppe Giugliano and Alessia Salemme and {De Longis}, Sara and Marialuisa Perrotta and Valentina D'Angelosante and Alessandro Landolfi and Raffaele Izzo and Valentina Trimarco",
year = "2018",
month = "2",
day = "7",
doi = "10.1186/s12979-017-0113-4",
language = "English",
volume = "15",
journal = "Immunity and Ageing",
issn = "1742-4933",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Effects of a new nutraceutical combination on cognitive function in hypertensive patients

AU - Giugliano, Giuseppe

AU - Salemme, Alessia

AU - De Longis, Sara

AU - Perrotta, Marialuisa

AU - D'Angelosante, Valentina

AU - Landolfi, Alessandro

AU - Izzo, Raffaele

AU - Trimarco, Valentina

PY - 2018/2/7

Y1 - 2018/2/7

N2 - Background: Chronic increased arterial blood pressure has been associated with executive dysfunction, slowing of attention and mental processing speed, and later with memory deficits. Due to the absence of a concrete therapeutic approach to this pathophysiological process, in the last decades there has been an increasing interest in the use of nutraceuticals, especially those with antioxidant properties, which own strong neuroprotective potential, that may help to improve cognitive function and to delay the onset of dementia. Results: We evaluated the effects of the treatment with a new nutraceutical preparation containing different molecules with potent antioxidant properties (AkP05, IzzeK®) and placebo on a cohort of thirty-six hypertensive patients. At baseline, neuropsychological evaluation, arterial stiffness and biochemical parameters of the subjects were comparable. After 6 months of treatment, there was a significant reduction of the augmentation index in the AkP05-treated group. Moreover, the measurement of cognitive function, evaluated with MoCA test and Word Match Testing, showed a significant improvement in patients receiving the active treatment. In addition, the group treated with nutraceutical reached a better Stroop test score, while subjects that received placebo did not showed any improvement. Finally, a positive relationship between SBP variation and the psychometric assessment with the EQ-VAS scale was observed only in the active treatment group. Conclusions: In this study, we demonstrated that the therapy with a new nutraceutical preparation is able to significantly increase the scores of important neuropsychological tests in hypertensive patients already on satisfactory blood pressure control. Although future studies are needed to better characterize the molecular mechanisms involved, these results candidate the new nutraceutical combination as a possible therapeutic strategy to support the cerebrovascular functions and delay the onset of dementia in hypertensive patients.

AB - Background: Chronic increased arterial blood pressure has been associated with executive dysfunction, slowing of attention and mental processing speed, and later with memory deficits. Due to the absence of a concrete therapeutic approach to this pathophysiological process, in the last decades there has been an increasing interest in the use of nutraceuticals, especially those with antioxidant properties, which own strong neuroprotective potential, that may help to improve cognitive function and to delay the onset of dementia. Results: We evaluated the effects of the treatment with a new nutraceutical preparation containing different molecules with potent antioxidant properties (AkP05, IzzeK®) and placebo on a cohort of thirty-six hypertensive patients. At baseline, neuropsychological evaluation, arterial stiffness and biochemical parameters of the subjects were comparable. After 6 months of treatment, there was a significant reduction of the augmentation index in the AkP05-treated group. Moreover, the measurement of cognitive function, evaluated with MoCA test and Word Match Testing, showed a significant improvement in patients receiving the active treatment. In addition, the group treated with nutraceutical reached a better Stroop test score, while subjects that received placebo did not showed any improvement. Finally, a positive relationship between SBP variation and the psychometric assessment with the EQ-VAS scale was observed only in the active treatment group. Conclusions: In this study, we demonstrated that the therapy with a new nutraceutical preparation is able to significantly increase the scores of important neuropsychological tests in hypertensive patients already on satisfactory blood pressure control. Although future studies are needed to better characterize the molecular mechanisms involved, these results candidate the new nutraceutical combination as a possible therapeutic strategy to support the cerebrovascular functions and delay the onset of dementia in hypertensive patients.

KW - Arterial stiffness

KW - Neuropsychological evaluation

KW - Nutraceutical

UR - http://www.scopus.com/inward/record.url?scp=85041841691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041841691&partnerID=8YFLogxK

U2 - 10.1186/s12979-017-0113-4

DO - 10.1186/s12979-017-0113-4

M3 - Article

AN - SCOPUS:85041841691

VL - 15

JO - Immunity and Ageing

JF - Immunity and Ageing

SN - 1742-4933

IS - 1

M1 - 7

ER -